A. Marije Hoogland - Concepedia

Author

A. Marije Hoogland

Also Known As

A M Hoogland, A Marije Hoogland, A. Marije Hoogland, A. Marije Hoogland (503748), A. Marije M. Hoogland, A.M. Hoogland, Agnes Marije Hoogland

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Erasmus University Rotterdam University Health Network Radboud University Medical Center Princess Margaret Cancer Centre

About

A. Marije Hoogland is an author at Erasmus MC specializing in medicine, urology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	573
2	Cell Biology	4	4	128
3	Engineering	2	2	34
4	Computer Science	1	1	19
5	Data Science	1	1	19

A. Marije Hoogland

Publications

Citations

H-Index

Page 1

	Year	Citations
Proteomic Profiling of Exosomes Leads to the Identification of Novel Biomarkers for Prostate Cancer Diederick Duijvesz, Kristin Burnum-Johnson, Marina Gritsenko, PLoS ONE	2013	202
A Prostate Cancer “ Nimbosus ”: Genomic Instability and SChLAP1 Dysregulation Underpin Aggression of Intraductal and Cribriform Subpathologies Melvin L.K. Chua, Winnie Lo, Melania Pintilie, European Urology UrologyMedicinePathologyCancer GenomicsCribriform Subpathologies	2017	180
ERG immunohistochemistry is not predictive for PSA recurrence, local recurrence or overall survival after radical prostatectomy for prostate cancer A. Marije Hoogland, Guido Jenster, Wytske M. van Weerden, Modern Pathology UrologySurgical OncologyPerineural InvasionGenitourinary CancerMedicine	2011	122
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice Geert J. van Leenders, Joost L. Boormans, C. J. Vissers, Modern Pathology UrologyOncologyGenitourinary CancerMedicinePathology	2011	108
SYK Is a Candidate Kinase Target for the Treatment of Advanced Prostate Cancer Veerander P.S. Ghotra, Shuning He, Geertje van der Horst, Cancer Research Syk Kinase InhibitorsSpleen Kinase SykCancer BiologyTumor BiologyOncology	2014	74
Specific detection of OCT3/4 isoform A/B/B1 expression in solid (germ cell) tumours and cell lines: confirmation of OCT3/4 specificity for germ cell tumours Martin A. Rijlaarsdam, H A D M van Herk, Ad Gillis, British Journal of Cancer	2011	64
The role of HOXC6 in prostate cancer development Agus Rizal Ardy Hariandy Hamid, A. Marije Hoogland, Frank Smit, The Prostate	2015	53
Novel long non-coding RNAs are specific diagnostic and prognostic markers for prostate cancer René Böttcher, A. Marije Hoogland, Natasja F. Dits, Oncotarget	2015	44
Validation of stem cell markers in clinical prostate cancer: α6-Integrin is predictive for non-aggressive disease A. Marije Hoogland, Esther I. Verhoef, Monique J. Roobol, The Prostate	2013	44
Low-Molecular-Weight Protein Tyrosine Phosphatase Predicts Prostate Cancer Outcome by Increasing the Metastatic Potential Roberta R. Ruela-de-Sousa, Elmer Hoekstra, A. Marije Hoogland, European Urology UrologyMedicineReceptor Tyrosine KinaseMetastatic PotentialProtein Phosphorylation	2015	35

Page 1